human immunodeficiency virus type1
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: * HIV-1 infected partner(s) who are assumed to be the source of HIV-1 transmission (donor) of patients who present with primary HIV-1 infection at the *Primo-SHM* study (recipient) in the AMC (MEC 03/059). * At least 18 years of age
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| * Sequence of the viral genome that is present in the HIV-1 donor as close as possible to the time of HIV-1 transmission. * Virus diversity (quasispecies) in the donor-recipient pairs half a year after HIV-1 transmission. * HLA type of donor-recipient pairs, availability of replication competent (pseudo)viruses from donor and recipient. | — |
Secondary
| Measure | Time frame |
|---|---|
| The relation between viral sequence dynamics and: * The HLA type of donor and recipient * The autologous neutralization profile * Host CTL responses * Viral fitness | — |
Countries
Netherlands
Outcome results
None listed